Ken Fisher Adamas Pharmaceuticals, Inc. Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Oct 26, 2021	SELL	N/A	-59,771 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	N/A	22,279 Added 59.42%	59,771 $316,000
Q1 2021 Apr 27, 2021	BUY	N/A	1,342 Added 3.71%	37,492 $180,000
Q4 2020 Jan 29, 2021	SELL	N/A	-22,840 Reduced 38.72%	36,150 $157,000
Q3 2020 Nov 10, 2020	BUY	N/A	27 Added 0.05%	58,990 $243,000
Q4 2019 Feb 12, 2020	SELL	N/A	-79,761 Reduced 57.5%	58,963 $223,000
Q2 2019 Jul 30, 2019	BUY	N/A	22,705 Added 19.57%	138,724 $860,000
Q1 2019 Apr 22, 2019	SELL	N/A	-5,440 Reduced 4.48%	116,019 $825,000
Q4 2018 Jan 25, 2019	BUY	N/A	3,342 Added 2.83%	121,459 $1.04 Million
Q3 2018 Oct 24, 2018	SELL	N/A	-28,012 Reduced 19.17%	118,117 $2.37 Million
Q2 2018 Jul 09, 2018	BUY	N/A	109,698 Added 301.11%	146,129 $3.78 Million
Q1 2018 May 11, 2018	SELL	N/A	-15,528 Reduced 29.89%	36,431 $871,000
Q1 2018 Apr 19, 2018	BUY	N/A	15,528 Added 42.62%	51,959 $1.24 Million
Q4 2017 Jan 24, 2018	SELL	N/A	-75 Reduced 0.21%	36,431 $1.24 Million
Q3 2017 Oct 17, 2017	BUY	N/A	36,506	36,506 $773,000

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.